Reviva Pharmaceuticals Holdings, Inc. SEC filings RVPH
Reviva Pharmaceuticals Holdings, Inc. has 413 filings in SEC EDGAR's recent list, going back to Jun 19, 2018. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Mar 30, 2026 | — |
| 424B5 | Prospectus supplement | Mar 19, 2026 | — |
| 424B5 | Prospectus supplement | Mar 18, 2026 | — |
| 424B5 | Prospectus supplement | Sep 19, 2025 | — |
| 424B5 | Prospectus supplement | Sep 18, 2025 | — |
| 424B5 | Prospectus supplement | Jun 26, 2025 | — |
| 424B5 | Prospectus supplement | Jun 25, 2025 | — |
| 424B5 | Prospectus supplement | May 30, 2025 | — |
| S-8 | Employee stock plan registration | Apr 3, 2025 | — |
| 424B5 | Prospectus supplement | Dec 18, 2024 | — |
| 424B5 | Prospectus supplement | Dec 16, 2024 | — |
| 424B5 | Prospectus supplement | Aug 22, 2024 | — |
| 424B5 | Prospectus supplement | May 29, 2024 | — |
| S-8 | Employee stock plan registration | May 17, 2024 | — |
| 424B4 | Prospectus | Feb 13, 2024 | — |
| S-3 | Shelf registration | Feb 2, 2024 | — |
| 424B5 | Prospectus supplement | Nov 17, 2023 | — |
| 424B3 | Prospectus | Apr 5, 2023 | — |
| S-8 | Employee stock plan registration | Mar 30, 2023 | — |
| POS AM | Form pos am | Mar 30, 2023 | — |
| 424B4 | Prospectus | Oct 18, 2022 | — |
| S-1 | Registration statement | Oct 6, 2022 | — |
| 424B5 | Prospectus supplement | Sep 7, 2022 | — |
| 424B3 | Prospectus | Mar 23, 2022 | — |
| 424B3 | Prospectus | Mar 23, 2022 | — |
| POS AM | Filing | Mar 18, 2022 | — |
| POS AM | Filing | Mar 18, 2022 | — |
| 424B3 | Prospectus | Feb 2, 2022 | — |
| 424B3 | Prospectus | Feb 2, 2022 | — |
| S-3 | Shelf registration | Jan 26, 2022 | — |
| 424B3 | Prospectus | Nov 15, 2021 | — |
| 424B3 | Prospectus | Nov 15, 2021 | — |
| 424B3 | Prospectus | Sep 21, 2021 | — |
| 424B3 | Prospectus | Sep 21, 2021 | — |
| 424B3 | Prospectus | Aug 16, 2021 | — |
| 424B3 | Prospectus | Aug 16, 2021 | — |
| 424B4 | Prospectus | May 28, 2021 | — |
| S-1MEF | Form s-1mef | May 26, 2021 | — |
| S-1/A | Amended registration statement | May 25, 2021 | — |
| S-1/A | Amended registration statement | May 19, 2021 | — |
| 424B3 | Prospectus | May 17, 2021 | — |
| 424B4 | Prospectus | May 17, 2021 | — |
| POS AM | Form pos am | May 12, 2021 | — |
| S-1/A | Amended registration statement | May 10, 2021 | — |
| S-1 | Registration statement | Apr 19, 2021 | — |
| 424B4 | Prospectus | Mar 29, 2021 | — |
| POS AM | Form pos am | Mar 25, 2021 | — |
| S-8 | Employee stock plan registration | Mar 22, 2021 | — |
| 424B3 | Prospectus | Jan 14, 2021 | — |
| 424B4 | Prospectus | Jan 12, 2021 | — |
| S-1/A | Amended registration statement | Jan 7, 2021 | — |
| S-1 | Registration statement | Dec 29, 2020 | — |
| 424B3 | Prospectus | Nov 12, 2020 | — |
| S-4/A | Filing | Nov 6, 2020 | — |
| S-4/A | Filing | Nov 3, 2020 | — |
| S-4/A | Filing | Oct 6, 2020 | — |
| S-4 | Registration for a merger or exchange | Aug 12, 2020 | — |
| 424B4 | Prospectus | Aug 22, 2018 | — |
| S-1MEF | Filing | Aug 20, 2018 | — |
| S-1/A | Amended registration statement | Aug 16, 2018 | — |
| S-1/A | Amended registration statement | Aug 6, 2018 | — |
| S-1 | Registration statement | Jul 20, 2018 | — |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RVPH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cupertino, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1742927
- Former names
- Tenzing Acquisition Corp. (until Dec 14, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.